Jakarta, Indonesia

Rifatul Widjhati


 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Rifatul Widjhati in Pharmaceutical Composition

Introduction

Rifatul Widjhati is an accomplished inventor based in Jakarta, Indonesia. He has made significant contributions to the field of pharmaceuticals, particularly in the area of treating inflammatory diseases and asthma. His innovative work has led to the development of a unique pharmaceutical composition that utilizes natural extracts.

Latest Patents

Rifatul Widjhati holds a patent for a pharmaceutical composition aimed at preventing or treating inflammatory diseases or asthma. This composition contains lagerstroemia ovalifolia extract or a fraction thereof as the active ingredient. The invention not only addresses the treatment of these conditions but also includes health functional foods and feed additives that utilize the same extract to improve health outcomes.

Career Highlights

Rifatul Widjhati is associated with the Korea Research Institute of Bioscience and Biotechnology. His work at this prestigious institution has allowed him to focus on innovative research and development in the pharmaceutical sector. His dedication to improving health through scientific advancements is evident in his patent and ongoing research efforts.

Collaborations

Rifatul has collaborated with notable colleagues such as Kyung Seop Ahn and Sei Ryang Oh. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to impactful innovations in the field.

Conclusion

Rifatul Widjhati's contributions to pharmaceutical innovations demonstrate his commitment to advancing healthcare solutions. His patent for a composition that addresses inflammatory diseases and asthma showcases the potential of natural extracts in medicine. His work continues to inspire future research and development in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…